The Transurban (ASX:TCL) share price has gone nowhere this year. What now?

Where is the Transurban share price going next?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It has been a subdued year for the Transurban Group (ASX: TCL) share price.

The toll road operator's shares are currently fetching $13.81, which means they are up just 1.5% in 2021.

Driver sitting in car, holding phone and looking frustrated

Image source: Getty Images

What now for the Transurban share price?

While the underperformance of the Transurban share price this year has been disappointing for shareholders, it could prove to be a buying opportunity for non-shareholders.

In fact, the team at Morgans believe the company's shares are attractively priced enough to be included in the broker's best ideas list for December.

According to the note, the broker has an add rating and $14.79 price target on the company's shares.

Based on the current Transurban share price, this implies potential upside of 7.1% over the next 12 months.

On top of that, Morgans believes that Transurban's dividend is poised to rebound quickly after being cut during the pandemic. The broker is forecasting a ~7% increase in FY 2022 to 39 cents per share and then a further 46% increase to 57 cents per share in FY 2023.

Based on the current Transurban share price, this implies yields of 2.8% and 4.1%, respectively.

Why does Morgans like Transurban?

Morgans likes Transurban for a number of reasons. This includes its exposure to regional population and employment growth and urbanisation, its market cap weighting, the quality of its assets, and its growth prospects.

The broker explained: "Given very high EBITDA margins, earnings are driven by traffic growth (with recovery from COVID) and toll escalation (roughly half at CPI and the remainder fixed c.4% pa)."

"We think TCL will continue to be attractive to investors given its market cap weighting (important for passive index tracking flows), the high quality of its assets, management team, balance sheet, and growth prospects. Watch for rapid recovery in DPS alongside traffic recovery and WestConnex acquisition prospects," it concluded.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Morgans names 2 ASX shares to buy and 1 to accumulate

What is the broker recommending investors do with these shares?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

2 ASX 200 shares to buy ahead of anticipated rally: expert

After a 9.1% drop between 27 February and 23 March, the ASX 200 reversed course last Tuesday.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

a miner holds his thumb up as he holds a device in his other hand.
Resources Shares

Experts name 3 ASX mining shares to buy after March sell-off

Investors took profits amid fears the fuel crisis could impact miners' production and earnings.

Read more »